ated with low complication rates. Self-limited, short-term complications include bruising and edema. Long-term complications such as clinically visible papules and subcutaneous nodules at the injection site have also been reported. [1] [2] [3] [4] [5] [6] [7] Herein, we present a case of multiple subcutaneous granulomas formation, which was confirmed by histopathological analysis, in an immunocompetent patient who received PLA injections for soft-tissue cosmetic enhancement.
A 62-year-old healthy woman presented to our clinic with a complaint of multiple firm skin-colored papules and subcutaneous nodules on the bilateral cheeks, chin, and temporal areas for 3-4 months ( Figure 1 ). She mentioned a history of PLA (Sculptra) injection (three doses of unknown volume and dilution) during the past year. Results of a skin biopsy revealed granulomatous dermatitis consisting of epithelioid histiocytes, numerous multinucleated and osteoclast-like giant cells. Many of these giant cells also had fusiform clefts in the cytoplasm or stellate-shaped inclusion bodies ( Figure 2 ). The intracytoplasmic fusiform clefts were filled with whitish birefringence crystalloid structures. The patient was treated with intralesional triamcinolone acetonide (3 mg/mL; 0.06-0.08 mL for each lesion, three treatment sessions; treatment duration: 2 weeks apart). After treatment, the subcutaneous nodules softened and gradually shrank. Delayed granulomatous reactions have been related to collagen, silicon, and hyaluronic acid. However, the rates of PLA-induced granulomas in the literature vary from 0.1% (reported by Vleggaar) 6 to 44% (reported in the VEGA study). 7 The discrepancy in the quoted rates of foreign-body granuloma formation after PLA injection may be attributed to differences in the injection techniques and the PLA concentrations used. Higher dilution volumes (5:1-7:1) are associated with lower rates.
1
Although the precise mechanism of PLA-induced granulomas is uncertain, there are some proposed theories including excess PLA deposition, an unequal distribution of PLA particles, formed local clustering due to the lack of a massage at the injection site, clustering of the large PLA particles, and different responses of various injection sites. A previous report suggests that the incidence of granuloma formation is greater at the periorbital skin. 4 Preparation of PLA 24 hours prior to the injection to allow even distribution of the particles and adequate dilution volumes are recommended to decrease this side effect. Treatment options for subcutaneous nodules are intralesional steroids, systemic steroids, systemic antibiotics, intense pulsed light, 5-fluorouracil, hydroxychloroquine, allopurinol, and surgical removal. [1] [2] [3] [4] [5] High doses of intralesional steroids (40-80 mg/mL) may be necessary for clinical resolution in some cases. 4 In summary, we report a case of nodule formation after injection of PLA. Doctors should be aware of the risks, and caution is necessary when using them. Adequate preparation, dilution, and massage at the injection site are essential to minimize the risk of side effects. In addition, proficient injection skills and sufficient understanding of the properties of PLA are crucial.
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